Severe necrotizing pancreatitis occurs in young female mice fed a choline-deficient and ethionine-supplemented (CDE) diet. Although the mechanism of the pancreatitis is unknown, one consequence of this diet is depletion of hepatic S-adenosylmethionine (SAM). SAM formation is catalyzed by methionine adenosyltransferases (MATs), which are encoded by liverspecific (MAT1A) and non-liver-specific (MAT2A) genes. In this work, we examined changes in pancreatic SAM homeostasis in mice receiving the CDE diet and the effect of SAM treatment. We found that both MAT forms are expressed in normal pancreas and pancreatic acini. After 48 h of the CDE diet, SAM levels decreased 50% and MAT1A-encoded protein disappeared via post-translational mechanisms, whereas MAT2A-encoded protein increased via pretranslational mechanisms. CDE-fed mice exhibited extensive necrosis, edema, and acute pancreatic inflammatory infiltration, which were prevented by SAM treatment. However, old female mice consuming the CDE diet that do not develop pancreatitis showed a similar fall in pancreatic SAM level. SAM was also protective in cerulein-induced pancreatitis in the rat, but the protection was limited. Although the pancreatic SAM level fell by more than 80% in the MAT1A knockout mice, no pancreatitis developed. This study thus provides several novel findings. First, the so-called liver-specific MAT1A is highly expressed in the normal pancreas and pancreatic acini. Second, the CDE diet causes dramatic changes in the expression of MAT isozymes by different mechanisms. Third, in contrast to the situation in the liver, where absence of MAT1A and decreased hepatic SAM level can lead to spontaneous tissue injury, in the pancreas the roles of SAM and MAT1A appear more complex and remain to be defined.
M ethionine adenosyltransferase (MAT) is a critical cellular enzyme that catalyzes the formation of S-adenosylmethionine (SAM), the principal biological methyl donor and the ultimate source of the propylamine moiety used in polyamine biosynthesis (1, 2) . The MAT gene is one of 482 genes required for survival of an organism (1) . In mammals, two different genes, MAT1A and MAT2A, encode for two homologous MAT catalytic subunits, α1 and α2 (3) (4) (5) . It is widely believed that MAT1A is expressed only in liver and that it encodes the α1 subunit found in two native MAT isozymes, which are either a dimer (MAT III) or a tetramer (MAT I) of this single subunit (5) . MAT2A encodes for a catalytic subunit (α2) found in a native MAT isozyme (MAT II), which is associated with a catalytically inactive regulatory subunit (β) in lymphocytes encoded by yet a third gene (5, 6) . MAT2A is widely distributed (3) (4) (5) . MAT2A also predominates in the fetal liver and is progressively replaced by MAT1A during liver development (7, 8) . In adult liver, increased expression of MAT2A is associated with rapid growth or de-differentiation of the liver (9) (10) (11) . Using a cell line model that differs only in the type of MAT expressed, we demonstrated that a switch in MAT expression in liver cancer (from MAT1A to MAT2A) plays an important pathogenetic role by facilitating liver cancer growth (12) . The influence of MAT expression on liver growth and injury was further demonstrated using a MAT1A knockout mouse model (13, 14) . In this model, hepatic SAM and reduced glutathione levels fell; the liver expressed markers of acute-phase reaction and increased growth, was more susceptible to injury, and developed spontaneous steatohepatitis (13) , oxidative stress, and hepatocellular carcinoma (14) .
Severe necrotizing pancreatitis occurs in young female mice fed a choline-deficient and ethionine-supplemented (CDE) diet (15, 16) . Although the mechanism of the pancreatitis is unknown, one consequence of the choline-deficient diet is depletion of hepatic SAM levels (13) . Prompted by our studies showing the importance of normal MAT expression and SAM homeostasis in the liver and accumulating evidence of SAM's therapeutic effect in various liver disorders (17) (18) (19) (20) , we investigated the possibility that SAM depletion may contribute to the development of pancreatitis in the CDE model. In this work, we discovered that MAT1A is highly expressed in the rat and mouse normal pancreas and, in particular, the pancreatic acinar cell. MAT1A-encoded protein disappeared after feeding of the CDE diet. The diet produced a decrease in the pancreatic content of SAM, and SAM supplementation prevented both the acute inflammatory response and necrosis of pancreatic parenchymal tissue that occurs in this pancreatitis model. However, SAM depletion by itself cannot explain pancreatitis because older female mice were resistant to CDE-induced pancreatitis despite a similar fall in pancreatic SAM level. MAT1A knockout mice also did not develop spontaneous pancreatitis despite a greater than 80% fall in SAM level. Thus, the roles of MAT1A and SAM in the pancreas are clearly different from those in the liver and remain to be defined.
MATERIALS AND METHODS

Materials
SAM was a kind gift from Dr. Pablo Ortiz (Boehringer Ingelheim, Madrid, Spain). 32 P-dCTP (3000 Ci/mmol) was purchased from New England Nuclear (DuPont, Boston, MA). Total RNA was isolated by using the TRI reagent (Molecular Research Center, Cincinnati, OH) or a kit from Promega (Madison, WI). All other reagents were of analytical grade and were obtained from commercial sources.
Animal experiments
Young (5-wk-old) female Swiss-Webster mice (Harlan, Madison, WI) each weighing 14.5 ± 0.2 g and old (14-months-old) female Swiss-Webster mice (Harlan) were used for the CDE model. Both the CDE diet and control diet were obtained from Harlan Teklad (Madison, WI) and were provided fresh to the animals every 12 h in 3-g aliquots. At each feeding, the CDE diet was supplemented with fresh 0.5% ethionine. The amount of food intake was quantified each day. Although animals given a CDE diet consumed less food than the mice given a control diet, SAM supplementation to the CDE diet did not influence the amount of food intake. At the indicated times after the initiation of the diets, animals were killed with CO 2 asphyxiation, and blood and pancreatic tissue were harvested for measurements of pancreatitis, MAT expression, and SAM levels as specified below.
Male Sprague-Dawley rats (Harlan), each weighing 100-150 g, were used for the cerulein model. Pancreatitis was induced by continuous i.v. infusion of cerulein at 5 µg/kg/h for 6 h as described previously (21) (22) (23) . At 6, 9, 18, and 24 h, animals were killed with CO 2 asphyxiation, and blood and pancreatic tissue were harvested for measurement of pancreatitis, MAT expression, and SAM levels as described below.
To assess the effect of SAM treatment in these two models, SAM was given i.p. at 15 mg/kg every 24 h to mice in the CDE model, and at 5 or 15 mg/kg to rats 10 min before the initiation of the cerulein infusion.
MAT1A knockout mice, heterozygous mice, and wild-type littermates (female, ages 4 to 6 months) (13, 14) were killed for determination of pancreatic SAM level and histology. 
Measurement of pancreatitis
Portions of the pancreas were prepared for histological examination by first fixing them in 10% zinc-buffered formalin followed by embedding them in paraffin and cutting them in 3-to 5-µm-thick sections for staining with hematoxylin and eosin. Stained sections were observed with a Nikon Diaphot inverted stage light microscope and photographed with Kodak Ectachrome 200 film. Immunohistochemical detection of neutrophils was done as described previously (23) (24) (25) . Serum amylase and lipase levels were measured with a Hitachi 707 analyzer (Antech Diagnostic, Irvine, CA).
Measurement of amylase in rat pancreatic secretion
Rat pancreatic secretion was obtained following the described method (23) . Animals were anesthetized (with 30 mg/kg ketamine + 3 mg/kg xylazine), and a catheter was inserted into the pancreatic duct through the sphincter of Oddi. After 30 min of stabilization, pancreatic biliary secretion was collected in 10-min fractions. Rats were treated with a single i.v. bolus of 15 mg/kg SAM or saline 20 min before receiving an i.v. bolus of 0.25 µg/kg cerulein to stimulate pancreatic secretion. After the cerulein bolus, pancreatic secretion was collected for 40 additional min. Amylase output in the fractions was measured by using the Phadebas Amylase test (Pharmacia & Upjohn Diagnostics, Uppsala, Sweden) and was expressed in units of amylase activity per minute.
Isolation of pancreatic acini
Pancreas was dissected from Sprague-Dawley rats, and dispersed pancreatic acini were isolated by a standard collagenase digestion method, as we described previously (21) (22) (23) .
RNA extraction
Total RNA was isolated from frozen pancreatic tissue specimens or isolated pancreatic acini with TRI reagent (Molecular Research Center) according to the method of Chomczynski and Sacchi (26) . RNA concentration was determined spectrophotometrically before use, and its integrity was checked by electrophoresis with subsequent ethidium bromide staining.
Northern hybridization analysis
Northern hybridization analysis was performed with total RNA via standard procedures, as described earlier using specific MAT1A and MAT2A probes (10, 11) . All probes were labeled with [ 32 P]dCTP by using a random-primer kit (Prime-It II Kit, Stratagene, La Jolla, CA). To ensure equal loading of RNA samples and transfer in each of the lanes, the same membranes were also rehybridized with 32 P-labeled 18S cDNA probes as described previously (11) . Autoradiography and densitometry (Gel Documentation System, Scientific Technologies, Carlsbad, CA, and NIH Image 1.60 software program) were used to quantify relative RNA levels. Results of Northern blot analysis were normalized to 18S.
Western blot analysis
The steady-state levels of MAT1A-and MAT2A-encoded proteins were determined by Western blot analysis as described before (11) .
SAM measurement
Pancreatic SAM levels were measured as described earlier (11, 27) . Because of the limited amount of sample per mouse, in some cases multiple samples from each treatment group were pooled for analysis. All metabolites are reported in nmol per mg pancreatic protein. Pancreatic Sadenosylhomocysteine levels were below the detection limits of the assay (11) .
Statistical analysis
Two-tailed nonpaired Student's t test was used for comparisons between two groups; ANOVA followed by Fisher's test was used for comparison of more than two groups. For changes in mRNA and protein levels, ratios of MAT1A and MAT2A to housekeeping control or Coomasie blue staining densitometric values were compared. Significance was defined by P < 0.05.
RESULTS
Pancreatic MAT expression
MAT1A and its encoded protein, α1, long thought to be expressed only in the liver, were highly expressed in normal rat and mouse pancreas (Figs. 1-3) . Furthermore, we found RNA expression of both MAT1A and MAT2A in isolated rat pancreatic acini (Fig. 1) . In fact, normal pancreas expressed predominantly MAT1A, as judged by the Northern and Western blot analyses, and little MAT2A. Dramatic changes in MAT expression were observed with use of the CDE diet in young female mice; however, these changes appeared to have occurred by different mechanisms. α1 disappeared by 48 h of use of the CDE diet (Fig. 3) despite nearly normal MAT1A mRNA levels (Fig. 2) . However, both MAT2A mRNA and its protein levels were greatly induced (Fig.  2and 3) . No significant changes in either of the MAT proteins or mRNA levels were observed in the cerulein model of pancreatitis (data not shown).
Pancreatic SAM levels
We next determined pancreatic SAM levels in these two models of pancreatitis. The pancreatic SAM level in young normal female mice was 0.54 ± 0.01 nmol/mg protein (mean ± SE from four samples). This fell to 0.27 ± 0.02 nmol/mg protein (mean ± SD from two pooled samples) and 0.30 ± 0.04 nmol/mg protein (mean ± SE from five samples) by 48 and 72 h of feeding the CDE diet, respectively. In old female mice, the pancreatic SAM level also fell by about 50% after 72 h of consumption of the CDE diet (data not shown).
The pancreatic SAM level in normal male rats treated with i.v. saline (control) was 0.41 ± 0.03 nmol/mg protein (mean ± SE from three animals). It decreased to 0.32 ± 0.03 nmol/mg protein in rats treated with i.v. cerulein (mean ± SE from seven animals, P = 0.07 vs. control).
Female MAT1A knockout mice had a much lower pancreatic SAM level compared with their wild-type littermates (wild type = 0.48 ± 0.01, heterozygotes = 0.21 ± 0.005, homozygotes = 0.08 ± 0.01 nmol/mg protein; n = 3 in each group, P<0.05 vs. wild type by ANOVA).
Pancreatic histology and serum amylase
As illustrated in Fig. 4 , use of the CDE diet in mice resulted in dramatic histological changes in the pancreas. The changes included a marked inflammatory response as well as necrosis and loss of parenchymal tissue. These histological changes were associated with an increase in the serum level of the pancreatic digestive enzyme amylase, which increased 6.4-fold after 72 h of feeding the CDE diet (Fig. 5) . Cerulein infusion also resulted in an increase in amylase levels, as described previously (21) (22) (23) 28) .
Pancreatic histology in MAT1A heterozygous and homozygous mice was unchanged from their wild-type littermates (data not shown).
Effect of SAM supplementation on pancreatic injury
To see if SAM supplementation might prevent pancreatic injury, CDE-fed and normal diet-fed young female mice were treated with SAM at 15 mg/kg i.p. every 24 h during feeding of the diet. SAM supplementation in the CDE mice prevented pancreatic injury, as determined histologically and biochemically (Figs. 4 and 5) . Quantification of pancreatic neutrophil infiltration (number of neutrophils per 100 acinar cells) revealed a significant decrease in the number of neutrophils by SAM treatment (control = 0, CDE = 8.67 ± 0.9, CDE plus SAM = 0.17 ± 0.17, n = 3 or 4 for each group, P<0.001 vs. CDE group by ANOVA).
Cerulein-or saline-treated rats received SAM at 5 or 15 mg/kg i.v. 10 min before the cerulein or saline infusion. SAM supplementation at 5 mg/kg (Fig. 5 ) and 15 mg/kg (data not shown) resulted in an attenuation of the cerulein-induced increase in serum amylase in rats. Even stronger inhibition (55%) was observed for the cerulein-induced increase in serum lipase level.
In control experiments, we studied whether the SAM treatment would not alter normal amylase secretion in response to a physiological dose of cerulein, measured as described in Materials and Methods (data not shown). We found that the SAM treatment did not impair cerulein interaction with its receptor on the acinar cell (i.e., cholecystokinin [CCK]-A receptor).
The effect of SAM supplementation in the cerulein model was, however, not as complete as in the CDE model of pancreatitis in the mouse. Furthermore, although protection by SAM was seen at the end of the cerulein infusion, if the animals were allowed to recover, then the amylase levels of the cerulein group and the cerulein plus SAM group became indistinguishable at 3, 12, and 18 h after termination of the cerulein infusion.
DISCUSSION
Evidence is accumulating that in the liver, a switch in MAT expression can affect SAM level and a decreased SAM level can predispose to injury (10) (11) (12) (13) (14) . A switch from MAT1A to MAT2A expression can result in lowering of the hepatic SAM level because of the different kinetic profiles and regulatory properties of the MAT isozymes (29) . The kinetic parameters varied in different studies depending on the purification procedure and the purity of the enzyme. The K m for methionine is lowest for MAT II (about 4-10 µM), intermediate for MAT I (23 µM to 1 mM), and highest for MAT III (215 µM to 7 mM), with different studies reporting different absolute values (30) (31) (32) (33) . The activity of MAT is also modulated by SAM, the product of the reaction it catalyzes. SAM strongly inhibits MAT II (IC 50 = 60 µM, which is close to the normal intracellular SAM concentration; see ref 2), whereas it minimally inhibits MAT I (IC 50 = 400 µM) and stimulates MAT III (up to eightfold at 500 µM SAM concentration) (33) . Because of these differences, the type of MAT expressed by a cell can influence the cell's steady-state SAM level and methylation status. Thus, the SAM level in cells that express only the MAT II isoform should be relatively unaffected by fluctuations in methionine availability because of the negative feedback inhibition. One caveat is the recently described function of the β or regulatory subunit, which renders MAT II more susceptible to feedback inhibition by SAM (6) . Interestingly, when lymphocytes become activated, this subunit disappears, which may explain the nearly fivefold increase in SAM levels compared with levels in resting cells (6) . In contrast, the rate of SAM synthesis and SAM levels increased with increasing methionine availability in cells that expressed liver-specific MAT (2) . Consistent with this, with a cell line model that differs only in the type of MAT expressed, cells that expressed MAT1A had the highest intracellular SAM level and DNA methylation, whereas cells that expressed MAT2A had the opposite (12) .
In the liver, absence of MAT1A and chronic SAM depletion led to spontaneous oxidative stress and development of steatohepatitis and hepatocellular carcinoma (13, 14) . Our finding that MAT1A is also highly expressed in the normal pancreas suggests that the same observations we have made in the liver may apply to the pancreas as well. Thus, a switch in MAT expression in the pancreas is likely to also affect the pancreatic SAM level, and whether a decrease in SAM level would predispose this organ to injury becomes intriguing. Our data show that the important role of MAT1A and SAM in the liver cannot be extrapolated to the pancreas.
The CDE model has been used extensively to study the pathogenesis of pancreatitis (15, 16) , but the mechanism of pancreatitis in this model remains unclear. It is known (15, 16, 34) that only young female mice are susceptible to pancreatitis with use of this diet. A choline-deficient diet is known to result in depletion of hepatic SAM levels (13) . Because pancreatic MAT expression mirrors that in the liver, we expected pancreatic SAM levels to fall in the CDE model. Indeed, we found that pancreatic SAM level fell 50% after 48 h of consumption of the CDE diet. On a mechanistic level, the fall in SAM level can be partly attributed to a dramatic switch in MAT expression. Specifically, MAT1A-encoded protein disappeared after 48 h with use of the CDE diet, but the MAT2A-encoded protein was greatly induced. Whether MAT activity was also inhibited is unclear at present and will require further study. Our findings indicate that the changes in pancreatic MAT isozymes are thus mediated by different mechanisms. In the case of MAT1A, the change appeared to be a post-translational effect. We previously observed a similar dissociation between hepatic MAT1A mRNA and α1 protein levels in two other models, after treatment with thioacetamide (11) and intragastric ethanol (35) . Thus, it is possible that the stability of MATI/III becomes impaired after certain experimental treatments. This possibility remains to be examined. In the case of MAT2A, the mechanism appears to be pretranslational because a comparable increase in MAT2A mRNA level also occurred. Whether this is due to increased gene transcription or mRNA stability is unknown and will require further study.
In the young female mice fed the CDE diet, the fall in pancreatic SAM level may play a role in the development of pancreatitis. This suggestion is supported by the fact that SAM supplementation almost completely prevented pancreatic injury. Previous studies have shown that methionine supplementation protected young female mice against CDE-induced pancreatitis (34) . Methionine is catabolized to SAM in all cells (1) , so that theoretically the protective effect may also have been mediated via SAM. However, a fall in SAM level alone cannot explain the development of pancreatitis with the CDE diet, because old female mice that are resistant to this form of injury showed a similar fall in pancreatic SAM level on this diet. Furthermore, MAT1A knockout mice had a profound reduction in pancreatic SAM level (83% lower) compared with wild-type controls but exhibited no pancreatic injury. Thus, it is unclear how SAM supplementation protects against CDE-induced pancreatitis in the young female mice. Factors influenced by age and sex are clearly important in determining the susceptibility of the animal to CDE-induced pancreatitis. The interaction of SAM and these factors remain to be determined.
In the liver, chronic SAM deficiency can affect the expression of numerous genes (13, 14) . SAM's protective effects in the liver at both the organ and the cellular levels have been well documented (1, 29, 36, 37) . In liver, a decreased SAM level can also potentiate the tumor necrosis factor α (TNF-α) response. This result is supported by studies by Chawla et al. that showed that rats with decreased hepatic SAM levels were predisposed to liver injury caused by lipopolysaccharide, which was prevented with exogenous SAM treatment (38) , and from our recent studies showing that in isolated rat hepatocytes SAM prevented the activation of nuclear factor-κB (NF-κB) (39) . Because NF-κB activation and TNF-α up-regulation both play important roles in the pathogenesis of pancreatitis (21, 22, 24, 25) , it will be important to examine whether SAM also modulates these pathways in acinar cells and whether they depend on age and/or sex.
To examine the role of SAM in a different model of pancreatitis, we studied its effect in rat cerulein pancreatitis. In the cerulein model, few changes in SAM or MAT protein levels were observed. This finding may reflect the fact that the animals were treated with the agent intravenously for 6 h and killed immediately after. Despite this, SAM supplementation blunted the injurious effect of cerulein. SAM's effect was not due to alteration of the CCK receptor signaling because CCK-induced amylase secretion was unaffected. Although SAM was protective immediately after the cerulein infusion, its protective effect disappeared after 3 h. This result may be due to the fact that SAM has a very short half-life (about 5 min) (40) and may require repeated dosing. This remains to be examined. Similar to the CDE-induced pancreatitis model, the mechanism of SAM's protection in this cerulein model is unclear at present.
In summary, the current work presents several novel findings. First, MAT1A, thought to be a liver-specific gene, is actually highly expressed in normal rat and mouse pancreas, and in particular, in the pancreatic acinar cell. Second, dramatic changes in MAT expression occur in the CDE pancreatitis model and by different mechanisms. Third, SAM supplementation prevents pancreatic injury in the CDE model and blunts pancreatic injury in the cerulein model. Fourth, despite the protective effect of SAM, SAM depletion alone does not result in pancreatic injury. Collectively, these data support the notion that SAM may regulate the inflammatory and cell death responses in the pancreas in some models of injury but that its role may be quite different from its generalized protective action in the liver. from normal rat pancreas or rat pancreatic acinar cells were analyzed by Northern blot hybridization with a 32 P-labeled MAT1A and MAT2A cDNA probe as described in Materials and Methods. Ethidium bromide staining of the gels was used to document equal loading. A) Representative pancreatic section stained with hematoxylin and eosin from mice fed the control diet and treated with SAM as described in Materials and Methods. The histology is normal and no different from that in animals not receiving SAM. B) Representative pancreatic section stained with hematoxylin and eosin from mice fed the CDE diet for 72 h. C) Representative pancreatic section stained with hematoxylin and eosin from mice fed the CDE diet for 72 h and treated with SAM (15 mg/kg, once daily). There were five to nine animals in each group. A) Amylase levels in mice that were fed the control or the CDE diet for 72 h and were given SAM (15 mg/kg, once daily) or vehicle (saline) as described in Materials and Methods. Values are means ± SE (five to nine animals in each group). *P < 0.05 compared with control.
# P < 0.05 compared with CDE diet alone. B) Amylase levels in rats that received 6-h intravenous infusions of 5 µg/kg/h cerulein (CR) or saline (control) and were given SAM (5 mg/kg, 10 min before start of the infusions) or vehicle as described in Materials and Methods. Values are means ± SE (three to nine animals in each group). *P < 0.05 compared with control.
# P < 0.05 compared with CR alone.
